“Factors Associated with Persistent Efficacy of Abrocitinib without Flare: A Multivariable Analysis of the JADE-REGIMEN Study” (2024) SKIN The Journal of Cutaneous Medicine, 8(2), p. s378. doi:10.25251/skin.8.supp.378.